Search results for "genital diseases"

showing 10 items of 669 documents

Allogeneic stem cell transplantation for renal cell carcinoma

2011

Allogeneic hematopoietic stem cell transplantation from a compatible donor has been utilized as adoptive immunotherapy in metastatic, cytokine-refractory renal cell carcinoma (RCC). Since the year 2000, several investigators have established that RCC is susceptible to a graft-versus-tumor effect: they reported that patients with renal cancer may have partial or complete disease responses, in the 20-40% range, after allogeneic transplantation following a reduced-intensity regimen. However, transplant-related mortality is still high in the 10-20% range, and responses are rarely durable. Experimental evidence suggests that donor-derived T cells and natural killer cells are the main mediators o…

Allogeneic transplantationT-Lymphocytesmedicine.medical_treatmentAntineoplastic AgentsHematopoietic stem cell transplantationurologic and male genital diseasesMinor histocompatibility antigenHumansTransplantation HomologousMedicineCytotoxic T cellPharmacology (medical)Molecular Targeted TherapyNeoplasm MetastasisCarcinoma Renal Cellbusiness.industryHematopoietic Stem Cell TransplantationImmunotherapyCombined Modality TherapyKidney NeoplasmsTissue DonorsKiller Cells NaturalTransplantationOncologyImmunologyStem cellbusinessCD8Expert Review of Anticancer Therapy
researchProduct

Fresh Human Orthotopic Ovarian Cortex Transplantation: Long-term Results

2006

An increasing number of young women are being diagnosed with cancer, and most cancer treatments have irreversibly negative effects on reproduction. Ovarian stimulation and preservation of oocytes or embryos is far from an ideal solution, in part because hormonal treatment may adversely affect some cancers. Another possibility is cryopreservation of ovarian tissue for later autotransplantation, but the ischemic damage caused by the procedure can lead to follicle loss. Using the ovarian medulla for orthotopic ovarian cortex transplantation might limit the risk of ischemia because the ovarian artery would assure a good blood supply. In addition, the medulla may have a role in follicular develo…

Anti-Mullerian Hormoneendocrine system diseasesmedicine.medical_treatmentPhysiologyPrimary Ovarian InsufficiencyOvarian MedullaOvarian arteryFollicle-stimulating hormoneIschemiaFollicular phaseProspective StudiesProgesteronemedia_commonbiologyRehabilitationObstetrics and GynecologyAnti-Müllerian hormoneGeneral MedicineMiddle Agedfemale genital diseases and pregnancy complicationsPremature ovarian failuremedicine.anatomical_structureFemaleAdultendocrine systemmedicine.medical_specialtyOvarian Cortexmedia_common.quotation_subjectUrologyOvaryHysterectomyInternal medicinemedicine.arterymedicineHumansOvulationGlycoproteinsCryopreservationHysterectomybusiness.industryOvarymedicine.diseaseAutotransplantationTransplantationTesticular HormonesEndocrinologyReproductive Medicinebiology.proteinFollicle Stimulating HormonebusinessObstetrical & Gynecological Survey
researchProduct

Mullarian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin-B

2005

Objective: To investigate Müllerian-inhibiting substance (MIS) levels in women with polycystic ovary syndrome (PCOS), as well as relationships to ovarian morphology, levels of inhibin B, and other reproductive hormones. Design: Prospective clinical study. Setting: Academic endocrinology centers in Palermo, Italy and New York. Patient(s): Forty-six women with PCOS, recruited on the basis of the classic criteria of chronic anovulation and hyperandrogenism, and 25 age-matched ovulatory controls. Intervention(s): Fasting blood was obtained in all subjects in the early follicular phase (days 5–6) after spontaneous or induced menses (in PCOS), and transvaginal ultrasounds were performed. Main Out…

Anti-Mullerian Hormoneendocrine systemmedicine.medical_specialtyendocrine system diseasesmedicine.medical_treatmentAnovulationPCOS MIS inhibin B ovarian volume insulinInternal medicinemedicineHumansInsulinInhibinsObesityProspective StudiesAndrostenedioneTestosteroneGlycoproteinsUltrasonographybusiness.industryInsulinOvaryHyperandrogenismObstetrics and Gynecologymedicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsTesticular HormonesEndocrinologyFollicular PhaseReproductive MedicineFemalebusinessLuteinizing hormoneBody mass indexBiomarkersAnovulationPolycystic Ovary Syndrome
researchProduct

Two-site ELISA for quantification of the terminal C5b-9 complement complex in plasma

1993

Abstract A quantitative ELISA procedure using monoclonal and polyclonal antibodies against neoantigens of the terminal C5b-9 complement complex has been developed. The ELISA was demonstrated to be both sensitive and reproducible. The normal range for C5b-9 determinations, defined as 2.5–97.5% interval of the values obtained in 76 healthy blood donors, was 3.12–10.3 AU/ml. The presence of rheumatoid factor did not affect the determination of C5b-9 as demonstrated by immunoabsorption studies.

Anticorps monoclonalbiologymedicine.drug_classChemistryImmunologychemical and pharmacologic phenomenaMonoclonal antibodyMolecular biologyfemale genital diseases and pregnancy complicationsPolyclonal antibodiesparasitic diseasesMonoclonalmedicinebiology.proteinImmunology and AllergyRheumatoid factorComplement membrane attack complexQuantitative analysis (chemistry)Normal rangeJournal of Immunological Methods
researchProduct

Lipid and Apoprotein Profile in Renal Transplant Recipients

1991

Lipid and apoprotein profiles of renal transplant recipients were compared with that of a group of uremic patients on hemodialytic treatment. Total cholesterol, HDL-cholesterol, apo AI and apo B were higher and triglycerides, apo CII, apo CIII and apo E lower in renal transplant patients. Type IIa and IIb were the prevalent phenotypes in renal transplant recipients.

Apolipoprotein Emedicine.medical_specialtyApolipoprotein Bbiologybusiness.industryurologic and male genital diseasesEndocrinologyRenal transplantTotal cholesterolInternal medicinebiology.proteinMedicinelipids (amino acids peptides and proteins)business
researchProduct

JAK3/STAT5/6 Pathway Alterations Are Associated with Immune Deviation in CD8+ T Cells in Renal Cell Carcinoma Patients

2010

To investigate the molecular mechanisms underlying altered T cell response in renal cell carcinoma (RCC) patients, we compared autologous and allogeneic CD8(+) T cell responses against RCC line from RCC patients and their HLA-matched donors, using mixed lymphocyte/tumor cell cultures (MLTCs). In addition, we analyzed the expression of molecules associated with cell cycle regulation. Autologous MLTC responder CD8(+) T cells showed cytotoxic activity against RCC cell lines; however the analysis of the distribution of CD8(+) T-cell subsets revealed that allogenic counterparts mediate superior antitumor efficacy. In RCC patients, a decreased proliferative response to tumor, associated with defe…

Article SubjectCell Survivallcsh:Biotechnologylcsh:MedicineEnzyme-Linked Immunosorbent AssayE2F4 Transcription FactorCD8-Positive T-Lymphocytesurologic and male genital diseaseslcsh:TP248.13-248.65Chromium IsotopesSTAT5 Transcription FactorTumor Cells CulturedHumansCarcinoma Renal CellInhibitor of Differentiation Protein 2Microscopy Confocallcsh:RCell CycleIntracellular Signaling Peptides and ProteinsJanus Kinase 3Flow Cytometryfemale genital diseases and pregnancy complicationsKidney NeoplasmsGene Expression Regulation NeoplasticCase-Control StudiesLymphocyte Culture Test MixedSTAT6 Transcription FactorCyclin-Dependent Kinase Inhibitor p27Research ArticleSignal TransductionJournal of Biomedicine and Biotechnology
researchProduct

Formation of basement membrane in extracapillary proliferates in rapidly progressive glomerulonephritis

1977

In the extracapillary proliferations (crescents) of the glomeruli in glomerulonephritis, basement membranes appear and in addition "secretory bodies" are formed in the cisternae of the rough endoplasmatic reticulum. The findings permit the conclusion that proliferated visceral epithelial cells are involved in the crescent formation to a greater extent than previously assumed.

Basement membranePathologymedicine.medical_specialtyurogenital systemChemistryKidney Glomerulusfood and beveragesGlomerulonephritisAnatomyEndoplasmic Reticulumurologic and male genital diseasesmedicine.diseaseBasement Membranefemale genital diseases and pregnancy complicationsPathology and Forensic MedicineGlomerulonephritismedicine.anatomical_structuremedicineHumansRapidly progressive glomerulonephritisReticulumVirchows Archiv B Cell Pathology
researchProduct

2013

Perlecan is a heparan sulfate proteoglycan assembled into the vascular basement membranes (BMs) during vasculogenesis. In the present study we have investigated vessel formation in mice, teratomas and embryoid bodies (EBs) in the absence of perlecan. We found that perlecan was dispensable for blood vessel formation and maturation until embryonic day (E) 12.5. At later stages of development 40% of mutant embryos showed dilated microvessels in brain and skin, which ruptured and led to severe bleedings. Surprisingly, teratomas derived from perlecan-null ES cells showed efficient contribution of perlecan-deficient endothelial cells to an apparently normal tumor vasculature. However, in perlecan…

Basement membraneendocrine systemmedicine.medical_specialtyMultidisciplinaryAngiogenesisfungiEmbryoid bodyPerlecanBiologyurologic and male genital diseasesFibroblast growth factorEmbryonic stem cellCell biologycarbohydrates (lipids)VasculogenesisEndocrinologymedicine.anatomical_structureInternal medicinemedicinebiology.proteinMicrovesselPLOS ONE
researchProduct

PSA and PSA Kinetics Thresholds for the Presence of 68Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer

2020

68Ga-PSMA-11 positron-emission tomography/computed tomography (PET/CT) is commonly used for restaging recurrent prostate cancer (PC) in European clinical practice. The goal of this study is to determine the optimum time for performing these PET/CT scans in a large cohort of patients by identifying the prostate-specific-antigen (PSA) and PSA kinetics thresholds for detecting and localizing recurrent PC. This retrospective analysis includes 581 patients with biochemical recurrence (BC) by definition. The performance of 68Ga-PSMA-11 PET/CT in relation to the PSA value at the scan time as well as PSA kinetics was assessed by the receiver-operating-characteristic-curve (ROC) generated by plottin…

Biochemical recurrenceCancer Researchmedicine.medical_treatment68Gallium-PSMA PET/CTurologic and male genital diseaseslcsh:RC254-282030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancer0302 clinical medicine<sup>68</sup>gallium-psma pet/ctprostate-specific-antigenPSA kinetics thresholdsbiochemical recurrenceMedicineoptimal cutoff levelPET-CTPsa kineticsbusiness.industryProstatectomylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensprostate cancermedicine.diseaseRadiation therapyProstate-specific antigenOncology030220 oncology & carcinogenesisRecurrent prostate cancerbusinessNuclear medicineCancers
researchProduct

Phosphorylation of cytochromes P450: First discovery of a posttranslational modification of a drug-metabolizing enzyme

2005

Cytochromes P450 (CYP) are important components of xenobiotic-metabolizing monooxygenases (CYP-dependent monooxygenases). Their regulation by induction, most commonly by transcriptional activation, mediated by xenobiotics, normally substrates of the corresponding CYP, is well known and has been widely studied. Our team has discovered an additional important regulation of xenobiotic-metabolizing CYPs pertaining to posttranslational modification by phosphorylation. Individual CYPs are phosphorylated by different protein kinases, leading to CYP isoenzyme-selective changes in the metabolism of individual substrates and consequent drastic changes in the control of genotoxic metabolites. Best stu…

Biophysicsurologic and male genital diseasesBiochemistryCytochrome P-450 Enzyme SystemAnimalsHumansheterocyclic compoundsPhosphorylationEnzyme inducerProtein kinase AMolecular BiologyTranscription factorRegulation of gene expressionbiologyKinaseorganic chemicalsCell Biologyrespiratory systemMonooxygenaseenzymes and coenzymes (carbohydrates)LiverBiochemistrybiology.proteinPhosphorylationProtein Processing Post-TranslationalNuclear localization sequenceMutagensBiochemical and Biophysical Research Communications
researchProduct